The present invention relates generally to bis-amide containing MMP inhibiting compounds, and more particularly to selectively deuterated bis-amide MMP-13 inhibiting compounds that exhibit increased stability or potency in relation to currently known MMP-13 inhibitors. Additionally, the present invention relates to methods for treating pain and inflammation in a patient comprising administering to the patient a pain-reducing effective amount of a present compound.
本发明一般涉及含有MMP抑制化合物的双酰胺,更具体地涉及选择性
氘代双酰胺MMP-13抑制化合物,该化合物相对于目前已知的MMP-13
抑制剂具有增加的稳定性或效力。此外,本发明还涉及一种治疗病人疼痛和炎症的方法,包括向病人施用一种现有化合物的减痛有效量。